About Dicerna Pharmaceuticals
Dicerna is an RNA interference-based biopharmaceutical company focused on the discovery and development of innovative treatments for rare, inherited diseases involving the liver and for other therapeutic areas in which the liver plays a key role.
State of Ownership
Research Fellow, University of Western Australia
Business Development Executive, Nature Publishing Group, Springer Nature
Sales Account Executive, Springer Nature
Director of Sales , SOLABS
CEO & Co-Founder, Zapnito